# Boehringer Ingelheim Biopharmaceuticals (China) Ltd. – FDA Inspection, Jul 24, 2026

Source: https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-biopharmaceuticals-china-ltd/0ce26aa4-613f-4fcb-be37-03eb4ca234cd
Source feed: FDA_Inspections

> FDA inspection 1330776 of Boehringer Ingelheim Biopharmaceuticals (China) Ltd., July 24, 2026. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1330776
- Company Name: Boehringer Ingelheim Biopharmaceuticals (China) Ltd.
- Inspection Date: 2026-07-24
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- [FDA Inspection 1218076 - 2023-06-09](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-biopharmaceuticals-china-ltd/ce95ea4c-4a33-431c-b721-ac05c17322f8)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/matthew-b-casale/e78481c6-5fbd-4723-a79c-167176395af8)

Company: https://www.keypedia.com/companies/boehringer-ingelheim-biopharmaceuticals-china-ltd/be450a8b-4f71-4f06-96b3-908a2ed1b580

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8